Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Friedman Paul ADirector |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $261K 487 sh |
| Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $480K 913 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $259K 480 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $561K 1,066 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $307K 588 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $507K 970 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $758K 1,480 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Brown Justin LPresident/Southwest Gas Corp. |  SWXSouthwest Gas Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $246K 3,028 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $355K 681 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $598K 1,135 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $692K 1,345 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $707K 1,363 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $822K 1,560 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $304K 575 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $628K 1,199 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $438K 840 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $814K 1,578 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $492K 960 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $254K 473 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 14 | Congleton JonDirector, Chief Executive Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $294K 9,119 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 14 | McCarthy Brian K.Pres.,Global Sales & Field Ops | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $281K 3,933 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 14 | Caldwell Nick V.Chief Product Officer |  PTONPELOTON INTERACTIVE, INC.Open-market sale · 10b5-1 plan | SELL | $176K 25.1K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 14 | McCarthy Brian K.Pres.,Global Sales & Field Ops | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $289K 4,067 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $160K 299 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $88K 166 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $145K 271 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $216K 400 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $246K 465 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $136K 256 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $217K 400 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $177K 332 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $229K 440 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $207K 385 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $154K 280 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $79K 148 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $149K 280 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $110K 200 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 11 | McCarthy Brian K.Pres.,Global Sales & Field Ops | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $140K 2,000 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 11 | Congleton JonDirector, Chief Executive Officer | MLYSMineralys Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $236K 7,117 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 11 | Baig SaqibChief Accounting Officer | PTONPELOTON INTERACTIVE, INC. Open-market sale · 10b5-1 plan | SELL | $35K 5,000 sh | Jan 13, 2026 traded Jan 9, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K